Exploring the heterogeneity of rare ovarian cancerDefining (epi)genomic transition from precursor lesion to invasive rare ovarian cancer

My research project continues on the work of my co-promotor, Dr. Els Van Nieuwenhuysen. She has already characterized rare ovarian tumors on DNA-level. Little is known today on these types of tumors. The approach is to deepdive into these groups of tumors (of which the bio-bank has already been established during my co-promoter's previous research) on RNA-level, methylation and histone modification. Furthermore, we try to look further into the rare tumor workgroup of ENGOT (European Network for Gynaecological Oncological Trial) in order to answer clinical questions about and treatment modalities for these types of tumors.